Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis

por van Mackelenbergh, Madelaine G., Stroes, Charlotte I., Spijker, René, van Eijck, Casper H.J., Wilmink, Johanna W., Bijlsma, Maarten F., van Laarhoven, Hanneke W.M.
Publicado 2019

Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with (18)F-DPA-714 PET/CT

por Verweij, Simone L., Stiekema, Lotte C. A., Delewi, Ronak, Zheng, Kang H., Bernelot Moens, Sophie J., Kroon, Jeffrey, Stroes, Charlotte I., Versloot, Miranda, Piek, Jan J., Verberne, Hein J., Stroes, Erik S. G.
Publicado 2018

From presentation to paper: Gender disparities in oncological research

por Dijksterhuis, Willemieke P.M., Stroes, Charlotte I., Tan, Wan‐Ling, Ithimakin, Suthinee, Calles, Antonio, van Oijen, Martijn G.H., Verhoeven, Rob H.A., Barriuso, Jorge, Oosting, Sjoukje F., Ivankovic, Daniela Kolarevic, Furness, Andrew J.S., Bozovic‐Spasojevic, Ivana, Gomez‐Roca, Carlos, van Laarhoven, Hanneke W.M.
Publicado 2019

Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric...

por Schokker, Sandor, van der Woude, Stephanie O., van Kleef, Jessy Joy, van Zoen, Daan J., van Oijen, Martijn G. H., Mearadji, Banafsche, Beenen, Ludo F. M., Stroes, Charlotte I., Waasdorp, Cynthia, Jibodh, R. Aarti, Creemers, Aafke, Meijer, Sybren L., Hooijer, Gerrit K. J., Punt, Cornelis J. A., Bijlsma, Maarten F., van Laarhoven, Hanneke W. M.
Publicado 2019

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)

por Stroes, Charlotte I, Schokker, Sandor, Khurshed, Mohammed, van der Woude, Stephanie O, Mathôt, Ron AA, Slingerland, Marije, de Vos-Geelen, Judith, Zucchetti, Massimo, Matteo, Cristina, van Dijk, Erik, Ylstra, Bauke, Thijssen, Victor, Derks, Sarah, Godefa, Tesfay, Dijksterhuis, Willemieke, Breimer, Gerben E, van Delden, Otto M, Verhoeven, Rob HA, Meijer, Sybren L, Bijlsma, Maarten F, van Laarhoven, Hanneke WM
Publicado 2022

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Respo...

por Stroes, Charlotte I., Schokker, Sandor, Molenaar, Remco J., Mathôt, Ron A. A., Bijlsma, Maarten F., van der Woude, Stephanie O., Belo Pereira, João P., Hooijer, Gerrit K. J., Verhoeven, Rob H. A., Cats, Annemieke, Grootscholten, Cecile, van Sandick, Johanna W., Creemers, Geert-Jan, Nieuwenhuijzen, Grard A. P., Haj Mohammad, Nadia, Ruurda, Jelle P., Meijer, Sybren L., Hulshof, Maarten C. C. M., van Berge Henegouwen, Mark I., van Laarhoven, Hanneke W. M.
Publicado 2021